1Geaves M. antiphospholipid antibodies and thrombsis. Lancet. 1999: 353:1348-1353
2Simantov R, Lo SK, Gharavi A, et al. Antiphospholipid antibodies actuate vascular endothelial cells. Lupus. 1996; 5 (5): 440-441
3Fields RA, Sibbitt WL, Toubbeh H, et al. Neuropsyehiatrie lupus erytbe-matosus, cerebral infarctions, and anticardiolipin antibod ies. Ann Rheum Dis. 1990; 49: 114
4Schorer AE, NickhamNW, Warson W, et al. Lupus anticoagulant induces a selective defect in thrombin-mdeiated endothelial prostacyclin release and platelet aggregation. Br J Haematol. 1989: 71: 399
5Harper MF, Haves PM, Lents BR, et al. Characterization of beta2- glycoprotein Ⅰ binding phospholipid membranes. Thromb Haemost. 1998,80(4): 610-4
6Rand iH. Molecular pathogenesis of the antiphospholipid syndrome. Circ Res. 2002,90: 29-37
7Faioni EM, Razzari C, Martinelli I, et al. Resistance to activated protein C in unseleeted patients with arterial and venous thrombosis. Am J Hematol. 1997,55:59-64
8Bokarewa MI, Bremme K, Falk G, et al. Studies on phospholipid antibodies, APC-resistance and associated mutation in the coagulation factor Ⅴ. Throm Res. 1995; 78:193-200
10Ferrara DE, Liu X, Espinola RG, Meroni PL, Abukhalaf I,Harris EN, et al. Inhibition of the thrombogenic and inflammatoryproperties of antiphospholipid antibodies by fluvastatin in an in vivo animal model. Arthritis Rheum. 2003; 48:3272-9
